May 11,ForbesRelease "2025 Forbes China Top 50 Artificial Intelligence Technology Enterprises"As a result, four sub-categories were also announced during the same period: 'AI Innovation Technology Company of the Year,' 'AI Innovative Application in Scenarios Company of the Year,' 'Emerging AI Company of the Year,' and 'Influential Figure in AI.'" The list includes multiple pharmaceutical and medical-related enterprises, includingXtalPi, Athena Eyes Technology Co.,Ltd., Winning Health Technology Group Co.,Ltd.Four Companies Ranked in TOP50, accounting for 8% of the total list, healthcare is tied with finance and chip. Among themCo-founder and CEO of XtalPiMa JianDr. also selected forInfluential Figures Sub-Selection. As the co-chair of the Zhangjiang AI New Drug R&D Alliance, he has led the development of an AI drug discovery platform that integrates quantum physics and deep learning algorithms, advancing over 20 innovative drugs into clinical trials and establishing a leading position for China in the AI pharmaceuticals field. The sub-selection has appearedFosun PharmaAndYunnan BaiyaoThe figure. Among themFosun PharmaRelying on the self-developed PharmAID pharmaceutical R&D decision-making intelligence platform, incubateFosun Xingmai AI Diagnostic Products, da Vinci Surgical Robot, Insilico Medicine AI Pipeline R&D, Zhe Yuan Technology Digital TwinAnd many other AI investments and strategic partnerships. Notably, in the 2024 list, there are 12 selected companies playing a key role in scenarios such as new drug development, medical imaging, assistive devices, electronic medical records, and health management, which has now dropped to 4. Except for Fosun X-Link and Insilico Medicine, which are still mentioned in this article,Besides, no company has been continuously shortlisted, which also shows that the AI medical track is accelerating iteration and evolution, forming a situation of "a hundred boats racing against each other, and a hundred flowers blooming." Recommended Reading